Monoclonal Antibodies (mAb) offer significant advantages including high specificity, minimal batch-to-batch variation, and virtually no cross-reactivity. KMD Bioscience provides premium Monoclonal Antibody Production services. Our experienced technical team, with years of expertise in Antibody Production, continuously optimizes the workflow to deliver high-quality antibodies rapidly, accumulating substantial experience in Monoclonal Antibody Production. The delivered antibodies are suitable for downstream applications such as IP, Co-IP, ELISA, and IHC.
To meet diverse client needs, KMD Bioscience offers two Monoclonal Antibody Production strategies. One utilizes traditional cell fusion technology, producing monoclonal antibodies via hybridoma generation from fusions including mouse-mouse, mouse-rat, or mouse-guinea pig cells, as well as fully human hybridomas. The alternative strategy employs species-independent Phage Display Antibody Library technology to construct hybridoma monoclonal antibodies. We provide comprehensive, one-stop services from gene synthesis through antibody production and characterization, and also offer high-quality Recombinant Antibody Production services.






0